Agmatine increases health-related quality of life

raisesVery limited evidenceFinding

01 · The sentence it was drawn from

“Expressed as percent of baseline values, significantly enhanced improvement in average pain measures and in quality of life scores occurred after treatment in the agmatine group (26.7% and 70.8%, respectively) as compared with placebo (6.0% [P </= 0.05] and 20.0% [P </= 0.05], respectively).”

Quoted verbatim from Safety and Efficacy of Dietary Agmatine Sulfate in Lumbar Disc-associated Radiculopathy. An Open-label, Dose-escalating Study Followed by a Randomized, Double-blind, Placebo-controlled Trial.

This finding among the 14 findings on its endpoint

agmatine

Health-related quality of life

raises

Who: Adults with herniated lumbar disc-associated radiculopathy, randomised double-blind to agmatine sulfate or placebo; analysed n = 31 agmatine and 30 placebo; abstract only
Dose studied: agmatine sulfate 2.670 g/day for 14 days

Very limited evidencePMID 20447305 · 2010

02 · The study

Study: RCT
Duration: 14 days

Evidence, by strength

strong
moderate
limited
very limitedthis finding
insufficient

03 · The paper

Pain medicine (Malden, Mass.)

Safety and Efficacy of Dietary Agmatine Sulfate in Lumbar Disc-associated Radiculopathy. An Open-label, Dose-escalating Study Followed by a Randomized, Double-blind, Placebo-controlled Trial.

2010PMID 20447305doi 10.1111/j.1526-4637.2010.00808.x

What else it reported1 finding · 1 compound · 1 endpoint

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M6ZEV4KFFMNEH4Q28AWTY4QP